Prospects for improved therapy in chronic obstructive pulmonary disease by the use of levalbuterol.

  • Jake Costello
  • Published 1999 in The Journal of allergy and clinical immunology


Like asthma, chronic obstructive pulmonary disease (COPD) is a chronic disease, the most prominent symptom of which is airway obstruction. Airway inflammation may be pathogenomic in both diseases, but only in COPD does inflammation predominate as a determinant of symptoms to make obstruction largely refractory to treatment. Despite a more limited degree of… (More)


  • Presentations referencing similar topics